Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 3
1983 4
1984 1
1985 9
1986 2
1987 3
1989 3
1990 2
1991 2
1992 5
1993 2
1994 2
1995 4
1996 2
1997 2
1998 1
1999 4
2000 3
2001 3
2002 2
2003 7
2004 7
2005 6
2006 10
2007 4
2008 9
2009 4
2010 9
2011 5
2012 9
2013 14
2014 8
2015 11
2016 3
2017 5
2018 6
2019 3
2020 7
2021 5
2022 9
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Insights in Inflammation Pharmacology: 2021.
Patrignani P, Steinhilber D. Patrignani P, et al. Front Pharmacol. 2022 May 27;13:928535. doi: 10.3389/fphar.2022.928535. eCollection 2022. Front Pharmacol. 2022. PMID: 35712698 Free PMC article. No abstract available.
Aspirin and Cancer.
Patrignani P, Patrono C. Patrignani P, et al. J Am Coll Cardiol. 2016 Aug 30;68(9):967-76. doi: 10.1016/j.jacc.2016.05.083. J Am Coll Cardiol. 2016. PMID: 27561771 Free article. Review.
Editorial: Eicosanoids in Cancer.
Markosyan N, Smyth EM, Patrignani P, Ricciotti E. Markosyan N, et al. Among authors: patrignani p. Front Pharmacol. 2021 Sep 9;12:765214. doi: 10.3389/fphar.2021.765214. eCollection 2021. Front Pharmacol. 2021. PMID: 34566667 Free PMC article. No abstract available.
Editorial: Women in Inflammation Pharmacology: 2021.
Patrignani P. Patrignani P. Front Pharmacol. 2022 Jul 11;13:973691. doi: 10.3389/fphar.2022.973691. eCollection 2022. Front Pharmacol. 2022. PMID: 35910361 Free PMC article. No abstract available.
Editorial: Insights in inflammation pharmacology: 2022.
Patrignani P, Ballerini P, Jakobsson PJ, Steinhilber D. Patrignani P, et al. Front Pharmacol. 2023 Jun 5;14:1223761. doi: 10.3389/fphar.2023.1223761. eCollection 2023. Front Pharmacol. 2023. PMID: 37342595 Free PMC article. No abstract available.
Editorial: Eicosanoids in cancer, Volume II.
Patrignani P, Smyth EM, Ricciotti E. Patrignani P, et al. Front Pharmacol. 2023 Jun 14;14:1224623. doi: 10.3389/fphar.2023.1224623. eCollection 2023. Front Pharmacol. 2023. PMID: 37388454 Free PMC article. No abstract available.
Therapeutic targeting of dysregulated cellular communication.
Schiavone S, Contursi A, Grande R, Patrignani P. Schiavone S, et al. Among authors: patrignani p. Ann Transl Med. 2017 May;5(10):222. doi: 10.21037/atm.2017.03.62. Ann Transl Med. 2017. PMID: 28603737 Free PMC article. No abstract available.
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.
Saul MJ, Baumann I, Bruno A, Emmerich AC, Wellstein J, Ottinger SM, Contursi A, Dovizio M, Donnini S, Tacconelli S, Raouf J, Idborg H, Stein S, Korotkova M, Savai R, Terzuoli E, Sala G, Seeger W, Jakobsson PJ, Patrignani P, Suess B, Steinhilber D. Saul MJ, et al. Among authors: patrignani p. FASEB J. 2019 Jun;33(6):6933-6947. doi: 10.1096/fj.201802547R. Epub 2019 Mar 28. FASEB J. 2019. PMID: 30922080
197 results